Refine by
Infection Prevention Articles & Analysis
130 news found
Staph, which is commonly carried on the skin or in the nose of healthy people, can sometimes cause infections, but most of these skin infections are minor. With MRSA, which is staph that is resistant to an antibiotic known as methicillin, and often resistant to other antibiotics as well, the infections can be very serious and sometimes even ...
International Infection Prevention Week (IIPW) has been championed by the Association for Professionals in Infection Control and Epidemiology since 1986. The annual event highlights the importance of infection prevention professionals and their efforts and control practices. These are crucial tasks as the ...
The Association for Professionals in Infection Control and Epidemiology (APIC) has championed International Infection Prevention Week since 1986. For 2024, the annual event is taking place from October 13th to the 19th. International Infection Prevention Week highlights the importance of ...
Their newest production discusses International Infection Prevention Week (IIPW). “For 2024, IIPW is taking place from October 13th to the 19th,” said Paul Cochrane, President of Cochrane & Associates and the IAQ Video Network. “Infection prevention professionals and their prevention ...
“Since 2009, the MRSA Survivors Network has organized this annual campaign to raise awareness and educate the public and healthcare providers on ways to prevent and mitigate infections due to MRSA and other pathogens. It’s important to note that MRSA infections can cause serious problems inside and outside of healthcare settings. ...
In May, the Centers for Disease Control and Prevention (CDC) announced the release of new guidance for preventing the spread of infections in K-12 schools. ...
Superbugs, also known as multidrug-resistant bacteria, are a growing concern as conventional antibiotics become less effective in treating infections. The development of vaccines against superbugs is an important area of research because vaccines can help prevent infections from occurring in the first place and reduce the need for antibiotics. By ...
Introduction Intraoperative irrigation is a commonly used method aimed at reducing microbial burden by removing tissue debris, metabolic waste, and tissue exudate from the surgical field prior to site closure.1 With the absence of universally established standard of care and robust clinical data, the selection of appropriate irrigation solution remains a topic of debate. Isotonic saline has ...
The Centers for Disease Control and Prevention (CDC) describes Klebsiella as a type of gram-negative bacteria that can cause different types of healthcare-associated infections (HAIs). ...
Mucormycetes are a group of fungi that can cause a rare but serious fungal infection known as mucormycosis reports the Centers for Disease Control and Prevention (CDC). ...
Through the Vizient contract, TOMI aims to enhance infection prevention and control measures across the healthcare industry. ...
The Centers for Disease Control and Prevention (CDC) even reports that about 30% of people carry Staphylococcus aureus in their nose. ...
Meanwhile, it is critical to keep the virus concentration low so as to detect infection and not saturate antibodies in the serum. It is significant to ensure that the detection is independent of viral concentrations and dependent only on the concentration and potency of tested sera. ...
(NASDAQ: TOMZ ) is a global decontamination and infection prevention company, providing environmental solutions for disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology ® (BIT™) platform. ...
(NASDAQ: TOMZ ) is a global decontamination and infection prevention company, providing environmental solutions for disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. ...
(NASDAQ: TOMZ ) is a global decontamination and infection prevention company, providing environmental solutions for disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology ® (BIT™) platform. ...
Destiny Pharma attended the discussion and was very pleased that the meeting reinforced the Company’s conviction in infection prevention as a key component in the management of serious hospital-acquired infections. ...
Targeting peak sales potential of $1 billion in the major markets Destiny Pharma plc (AIM: DEST), a clinical stage innovative biotechnology company focused on the development of novel medicines that can prevent life-threatening infections, is pleased to announce that it has now finalised plans for its Phase 3 studies for its late-stage clinical asset, XF-73 ...
The objective of this research program is unique in that its goal is to prevent infections rather than treat them after they have already taken hold. This preventative approach will allow Lumen to develop an inexpensive, biologic drug cocktail against the most frequent, multi-drug resistant infecting pathogens. ...
Destiny Pharma plc (AIM: DEST), a clinical stage innovative biotechnology company focused on the development of novel medicines that can prevent life-threatening infections, is pleased to announce the commencement of an Investigational New Drug (IND) enabling safety study with its novel XF-73 Dermal formulation. ...